Clinical Research Consulting

1. BioNTech SE $1,547,484 85 payments
2. Seqirus USA Inc $670,529 797 payments
3. Pfizer Inc. $50,311 61 payments
4. Valneva Austria GmbH $22,857 1 payment
5. Novavax Inc $19,562 2 payments

1. Bnt162-17 $1,467,111 54 payments
2. The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older $240,162 245 payments
3. A Phase 3/3b Randomized Observer-blind Multicenter Clinical Study to Evaluate the Efficacy Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine Compared to a Non-Influenza Vaccine in Adults >=50 Years of Age $196,549 92 payments
4. A Phase 2, Randomized, Study to Evaluate Safety and Immunogenicity of One or Two Heterologous Booster Vaccinations With an MF59-adjuvanted, Cell Culture-derived H5N6 Influenza Vaccine in Adults Primed With MF59- adjuvanted, Cell Culture-derived H5N1 Influenza Vaccine or Unprimed. $113,105 243 payments
5. A Phase 2b, Randomized, Observer-Blind, Antigen and Adjuvant Dose-Confirmation Clinical Study to Evaluate Safety and Immunogenicity of Different Formulations of MF59-Adjuvanted Quadrivalent Subunit Inactivated Cell-derived Influenza Vaccine (aQIVc) in Older Adults =50 Years of Age $90,427 178 payments
6. Pre-commercial $46,170 13 payments
7. Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults $30,287 39 payments
8. Bnt162-21 $25,352 13 payments
9. Alternative Schedule Study for Vla15, A Multivalent Recombinant Ospa Based Vaccine Candidate Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years - A Randomized, Controlled, Observer-Blind Phase 2 Study $22,857 1 payment
10. A Phase 2, Randomized, Observer-Blinded Study to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle and Quadrivalent Hemagglutinin Nanoparticle Influenza Combination Vaccine With Matrix-M™ Adjuvant in Healthy Participants greater than or equal to 50 years of age, to less than or equal to 80 Years of Age $19,562 2 payments

1. Patient care $55,021 18 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.